Balance Sheet - BridgeBio Oncology Therapeutics, Inc. (BBOT)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | |
|---|---|---|---|---|---|
| Total cash and short-term investments | 425.46 | 126.48 | 0.25 | 0.00 | 0.00 |
| Accounts receivable, net | 0.39 | ||||
| Other current assets | -0.39 | 0.25 | 1.96 | ||
| Total current assets | 425.46 | 1.95 | 3.94 | ||
| Total non-current assets | 22.92 | 192.47 | 0.33 | 0.14 | 0.14 |
| Total assets | 448.38 | 194.42 | 0.33 | 0.14 | 0.14 |
| Total current liabilities | 35.04 | 0.19 | 0.40 | 0.17 | 0.16 |
| Total non-current liabilities | 2.24 | 5.52 | 104.81 | ||
| Total liabilities | 37.29 | 5.71 | 0.40 | 0.17 | 0.16 |
| Total stockholders' equity | 411.10 | 188.72 | -0.06 | -0.02 | -0.02 |
| Common shares outstanding | 31 | 17 | 20 | 20 | 20 |
Show Quarterly Balance Sheet
Balance Sheet - BridgeBio Oncology Therapeutics, Inc. (BBOT)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 252.28 | 425.46 | 468.29 | 131.40 | 135.72 | 126.48 | 1.79 | 1.81 | 1.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Accounts receivable, net | 0.15 | 0.39 | 0.23 | 1.08 | 0.04 | |||||||||
| Other current assets | 14.08 | -0.39 | 7.50 | 9.87 | 5.57 | 0.25 | 0.26 | 0.26 | 0.27 | |||||
| Total current assets | 266.50 | 425.46 | 476.01 | 142.35 | 141.33 | 1.95 | 2.04 | 2.08 | 2.11 | |||||
| Total non-current assets | 151.14 | 22.92 | 8.78 | 8.91 | 8.51 | 192.47 | 190.29 | 187.80 | 185.42 | 0.33 | 0.14 | 0.14 | ||
| Total assets | 417.65 | 448.38 | 484.79 | 151.25 | 149.84 | 194.42 | 192.33 | 189.87 | 187.53 | 0.33 | 0.14 | 0.14 | ||
| Total current liabilities | 43.26 | 35.04 | 35.71 | 27.25 | 24.06 | 0.19 | 0.13 | 0.08 | 0.02 | 0.40 | 0.17 | 0.17 | ||
| Total non-current liabilities | 2.11 | 2.24 | 2.38 | 351.74 | 325.81 | 5.52 | 5.52 | 5.52 | 5.52 | |||||
| Total liabilities | 45.37 | 37.29 | 38.09 | 378.99 | 349.87 | 5.71 | 5.65 | 5.60 | 5.54 | 0.40 | 0.17 | 0.17 | ||
| Total stockholders' equity | 372.28 | 411.10 | 446.70 | -227.73 | -200.03 | 188.72 | 186.69 | 184.28 | 181.99 | -0.06 | -0.02 | -0.02 | ||
| Common shares outstanding | 31 | 31 | 24 | 24 | 24 | 17 | 24 | 24 | 22 | 20 | 20 | 20 | 20 | 20 |